KBC Group NV Has $36.52 Million Stake in Molina Healthcare, Inc. (NYSE:MOH)

KBC Group NV grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 14.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 125,486 shares of the company’s stock after buying an additional 15,993 shares during the period. KBC Group NV owned approximately 0.22% of Molina Healthcare worth $36,522,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in MOH. NFJ Investment Group LLC bought a new stake in Molina Healthcare in the third quarter valued at $7,432,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its stake in shares of Molina Healthcare by 406.6% in the 3rd quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 21,996 shares of the company’s stock valued at $7,579,000 after purchasing an additional 17,654 shares in the last quarter. Raymond James & Associates grew its holdings in shares of Molina Healthcare by 59.9% in the 3rd quarter. Raymond James & Associates now owns 42,298 shares of the company’s stock worth $14,574,000 after purchasing an additional 15,840 shares during the last quarter. Integrated Investment Consultants LLC bought a new stake in shares of Molina Healthcare in the 3rd quarter worth about $4,716,000. Finally, Citigroup Inc. increased its position in shares of Molina Healthcare by 18.8% during the 3rd quarter. Citigroup Inc. now owns 84,770 shares of the company’s stock worth $29,208,000 after purchasing an additional 13,387 shares in the last quarter. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Stock Up 2.4 %

Shares of NYSE MOH opened at $311.68 on Tuesday. Molina Healthcare, Inc. has a 1 year low of $272.69 and a 1 year high of $423.92. The firm’s 50-day moving average is $296.02 and its 200-day moving average is $317.56. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $17.83 billion, a PE ratio of 15.83, a price-to-earnings-growth ratio of 0.94 and a beta of 0.54.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of recent analyst reports. Barclays boosted their price target on shares of Molina Healthcare from $359.00 to $372.00 and gave the company an “equal weight” rating in a research report on Friday, October 25th. StockNews.com upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company increased their target price on Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a report on Monday, November 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Molina Healthcare presently has an average rating of “Hold” and a consensus target price of $359.18.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.